Literature DB >> 25253916

Preparation of 1,5-Disubstituted 1,2,3-Triazoles via Ruthenium-catalyzed Azide Alkyne Cycloaddition.

James S Oakdale, Valery V Fokin, Satoshi Umezaki, Tohru Fukuyama.   

Abstract

Entities:  

Year:  2013        PMID： 25253916      PMCID： PMC4171046          DOI： 10.15227/orgsyn.090.0096

Source DB:  PubMed          Journal:  Organic Synth        ISSN： 0078-6209


× No keyword cloud information.
  17 in total

Review 1.  On inventing reactions for atom economy.

Authors:  Barry M Trost
Journal:  Acc Chem Res       Date:  2002-09       Impact factor: 22.384

2.  A study of the scope and regioselectivity of the ruthenium-catalyzed [3 + 2]-cycloaddition of azides with internal alkynes.

Authors:  Max M Majireck; Steven M Weinreb
Journal:  J Org Chem       Date:  2006-10-27       Impact factor: 4.354

3.  3'-[4-Aryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase.

Authors:  Sara Van Poecke; Ana Negri; Federico Gago; Ineke Van Daele; Nicola Solaroli; Anna Karlsson; Jan Balzarini; Serge Van Calenbergh
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

4.  Ruthenium-catalyzed cycloaddition of alkynes and organic azides.

Authors:  Li Zhang; Xinguo Chen; Peng Xue; Herman H Y Sun; Ian D Williams; K Barry Sharpless; Valery V Fokin; Guochen Jia
Journal:  J Am Chem Soc       Date:  2005-11-23       Impact factor: 15.419

5.  Ruthenium(II)-catalyzed selective intramolecular [2 + 2 + 2] alkyne cyclotrimerizations.

Authors:  Yoshihiko Yamamoto; Takayasu Arakawa; Ryuji Ogawa; Kenji Itoh
Journal:  J Am Chem Soc       Date:  2003-10-08       Impact factor: 15.419

6.  Mechanism for the cyclotrimerization of alkynes and related reactions catalyzed by CpRuCl.

Authors:  Karl Kirchner; Maria José Calhorda; Roland Schmid; Luís F Veiros
Journal:  J Am Chem Soc       Date:  2003-09-24       Impact factor: 15.419

7.  Ruthenium-catalyzed azide-alkyne cycloaddition: scope and mechanism.

Authors:  Brant C Boren; Sridhar Narayan; Lars K Rasmussen; Li Zhang; Haitao Zhao; Zhenyang Lin; Guochen Jia; Valery V Fokin
Journal:  J Am Chem Soc       Date:  2008-06-21       Impact factor: 15.419

8.  Probing the bioactive conformation of an archetypal natural product HDAC inhibitor with conformationally homogeneous triazole-modified cyclic tetrapeptides.

Authors:  W Seth Horne; Christian A Olsen; John M Beierle; Ana Montero; M Reza Ghadiri
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

9.  Protein prosthesis: 1,5-disubstituted[1,2,3]triazoles as cis-peptide bond surrogates.

Authors:  Annie Tam; Ulrich Arnold; Matthew B Soellner; Ronald T Raines
Journal:  J Am Chem Soc       Date:  2007-10-03       Impact factor: 15.419

10.  Chitinase inhibitors: extraction of the active framework from natural argifin and use of in situ click chemistry.

Authors:  Tomoyasu Hirose; Toshiaki Sunazuka; Akihiro Sugawara; Ayako Endo; Kanami Iguchi; Tsuyoshi Yamamoto; Hideaki Ui; Kazuro Shiomi; Takeshi Watanabe; K Barry Sharpless; Satoshi Omura
Journal:  J Antibiot (Tokyo)       Date:  2009-03-27       Impact factor: 2.649
View more
  2 in total

1.  Ruthenium-Catalyzed Azide-Thioalkyne Cycloadditions in Aqueous Media: A Mild, Orthogonal, and Biocompatible Chemical Ligation.

Authors:  Paolo Destito; José R Couceiro; Hélio Faustino; Fernando López; José L Mascareñas
Journal:  Angew Chem Int Ed Engl       Date:  2017-08-03       Impact factor: 15.336

2.  Strong Inhibitory Activity and Action Modes of Synthetic Maslinic Acid Derivative on Highly Pathogenic Coronaviruses: COVID-19 Drug Candidate.

Authors:  Raya Soltane; Amani Chrouda; Ahmed Mostafa; Ahmed A Al-Karmalawy; Karim Chouaïb; Abdelwaheb Dhahri; Rami Adel Pashameah; Ahlam Alasiri; Omnia Kutkat; Mahmoud Shehata; Hichem Ben Jannet; Jawhar Gharbi; Mohamed A Ali
Journal:  Pathogens       Date:  2021-05-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.